Skip to main content
Earnings Labs
Relmada Therapeutics, Inc. logo

Relmada Therapeutics, Inc. (RLMD) Earnings

NASDAQ·Healthcare·Biotechnology

$5.50

+3.96%

Mkt Cap $556.97M

EPS — Estimate vs Actual

Mkt Cap

$556.97M

P/E

Fwd P/E

P/S

Rev TTM

EPS TTM

-$1.11